Search Results

There are 10062 results for: content related to: Position statement on the use of antiretroviral therapy to reduce HIV transmission, J anuary 2013: The B ritish HIV A ssociation ( BHIVA ) and the E xpert A dvisory G roup on AIDS ( EAGA )

  1. You have full text access to this OnlineOpen article
    Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life

    HIV Medicine

    A Bamford, A Turkova, H Lyall, C Foster, N Klein, D Bastiaans, D Burger, S Bernadi, K Butler, E Chiappini, P Clayden, M Della Negra, V Giacomet, C Giaquinto, D Gibb, L Galli, M Hainaut, M Koros, L Marques, E Nastouli, T Niehues, A Noguera-Julian, P Rojo, C Rudin, HJ Scherpbier, G Tudor-Williams, SB Welch and (PENTA Steering Committee)

    Article first published online : 3 FEB 2015, DOI: 10.1111/hiv.12217

  2. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Article first published online : 14 FEB 2014, DOI: 10.1111/hiv.12136

  3. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 321–329, G Sampériz, D Guerrero, M López, JL Valera, A Iglesias, Á Ríos, A Campins, E Sala, J Murillas, B Togores, J Palmer, M Rodriguez, JB Soriano, J Sauleda, M Riera and A Agusti

    Article first published online : 8 DEC 2013, DOI: 10.1111/hiv.12117

  4. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey

    HIV Medicine

    Volume 16, Issue 4, April 2015, Pages: 230–239, E Rosenthal, C Roussillon, D Salmon-Céron, A Georget, S Hénard, T Huleux, I Gueit, E Mortier, D Costagliola, P Morlat, G Chêne, P Cacoub and the Mortalité 2010 and GERMIVIC study groups

    Article first published online : 18 DEC 2014, DOI: 10.1111/hiv.12204

  5. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 478–487, M Meresse, L March, C Kouanfack, R-C Bonono, S Boyer, G Laborde-Balen, A Aghokeng, M Suzan-Monti, E Delaporte, B Spire, M-P Carrieri, C Laurent and Stratall ANRS 12110/ESTHER Study Group

    Article first published online : 3 MAR 2014, DOI: 10.1111/hiv.12140

  6. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada

    HIV Medicine

    Volume 16, Issue 2, February 2015, Pages: 76–87, H Samji, TE Taha, D Moore, AN Burchell, A Cescon, C Cooper, JM Raboud, MB Klein, MR Loutfy, N Machouf, CM Tsoukas, JSG Montaner, RS Hogg and for the Canadian Observational Cohort (CANOC) Collaboration

    Article first published online : 1 SEP 2014, DOI: 10.1111/hiv.12173

  7. Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data

    HIV Medicine

    Volume 16, Issue 5, May 2015, Pages: 297–306, J Vingerhoets, V Calvez, P Flandre, A-G Marcelin, F Ceccherini-Silberstein, C-F Perno, M Mercedes Santoro, R Bateson, M Nelson, A Cozzi-Lepri, J Grarup, J Lundgren, F Incardona, R Kaiser, A Sonnerborg, B Clotet, R Paredes, HF Günthard, B Ledergerber, A Hoogstoel, S Nijs, L Tambuyzer, L Lavreys, M Opsomer and on behalf of the Etravirine Cohort Study Group

    Article first published online : 14 JAN 2015, DOI: 10.1111/hiv.12218

  8. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 330–338, E Martinez, A Gonzalez-Cordon, E Ferrer, P Domingo, E Negredo, F Gutierrez, J Portilla, A Curran, D Podzamczer, J Murillas, JI Bernardino, I Santos, JA Carton, J Peraire, J Pich, I Perez, JM Gatell and for the ATADAR Study Group

    Article first published online : 12 JAN 2014, DOI: 10.1111/hiv.12121

  9. You have free access to this content
    Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    HIV Medicine

    Volume 16, Issue S1, April 2015, Pages: 64–76, AJ Rodger, FC Lampe, AE Grulich, M Fisher, G Friedland, N Phanuphak, JR Bogner, LC Pereira, C Rietmeijer, W Burman, AN Phillips and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

    Article first published online : 25 FEB 2015, DOI: 10.1111/hiv.12235

  10. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions

    HIV Medicine

    Volume 15, Issue 7, August 2014, Pages: 385–395, JL Marcus, T Buisker, T Horvath, KR Amico, JD Fuchs, SP Buchbinder, RM Grant and AY Liu

    Article first published online : 24 FEB 2014, DOI: 10.1111/hiv.12132

  11. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation

    HIV Medicine

    M Vassallo, J Durant, C Lebrun-Frenay, R Fabre, M Ticchioni, S Andersen, F DeSalvador, A Harvey-Langton, B Dunais, I Cohen-Codar, N Montagne, E Cua, L Fredouille-Heripret, M Laffon, J Cottalorda, P Dellamonica and C Pradier

    Article first published online : 18 MAY 2015, DOI: 10.1111/hiv.12246

  12. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy

    HIV Medicine

    S Hattab, M Guiguet, G Carcelain, S Fourati, A Guihot, B Autran, F Caby, A-G Marcelin, D Costagliola and C Katlama

    Article first published online : 6 MAY 2015, DOI: 10.1111/hiv.12257

  13. You have free access to this content
    Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study

    HIV Medicine

    Volume 14, Issue 6, July 2013, Pages: 327–336, E Ribera, M Larrousse, A Curran, E Negredo, B Clotet, V Estrada, J Sanz, J Berenguer, R Rubio, F Pulido, P Ferrer, ML Alvarez, S Arterburn and E Martínez

    Article first published online : 9 JAN 2013, DOI: 10.1111/hiv.12011

  14. Patients who present late to HIV care and associated risk factors in Nigeria

    HIV Medicine

    Volume 15, Issue 7, August 2014, Pages: 396–405, PA Agaba, ST Meloni, HM Sule, OO Agbaji, PN Ekeh, GC Job, N Nyango, PO Ugoagwu, GE Imade, JA Idoko and PJ Kanki

    Article first published online : 20 JAN 2014, DOI: 10.1111/hiv.12125

  15. You have free access to this content
    Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study

    HIV Medicine

    Volume 16, Issue 1, January 2015, Pages: 3–14, J Schäfer, J Young, E Bernasconi, B Ledergerber, D Nicca, A Calmy, M Cavassini, H Furrer, M Battegay, HC Bucher and the Swiss HIV Cohort Study

    Article first published online : 8 MAY 2014, DOI: 10.1111/hiv.12165

  16. Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada

    HIV Medicine

    L Brunet, EEM Moodie, J Cox, J Gill, C Cooper, S Walmsley, A Rachlis, M Hull, MB Klein and for theCanadian Coinfection Cohort Study Investigators

    Article first published online : 3 JUL 2015, DOI: 10.1111/hiv.12279

  17. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database

    HIV Medicine

    Volume 15, Issue 2, February 2014, Pages: 77–85, SH Han, J Zhou, MP Lee, H Zhao, Y-MA Chen, N Kumarasamy, S Pujari, C Lee, SFS Omar, R Ditangco, N Phanuphak, S Kiertiburanakul, R Chaiwarith, TP Merati, E Yunihastuti, J Tanuma, V Saphonn, AH Sohn, JY Choi and on behalf of the TREAT Asia HIV Observational Database

    Article first published online : 27 AUG 2013, DOI: 10.1111/hiv.12073

  18. Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV

    HIV Medicine

    Volume 15, Issue 6, July 2014, Pages: 347–354, V Mave, D Kadam, A Kinikar, N Gupte, D Bhattacharya, R Bharadwaj, K McIntire, V Kulkarni, U Balasubramanian, N Suryavanshi, C Thio, P Deshpande, J Sastry, R Bollinger, A Gupta, R Bhosale and the SWEN India and Byramjee-Jeejeebhoy Medical College Clinical Trials Unit Study team

    Article first published online : 14 JAN 2014, DOI: 10.1111/hiv.12120

  19. You have free access to this content
    Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy

    HIV Medicine

    Volume 16, Issue 1, January 2015, Pages: 48–56, J-P Routy, JB Angel, M Patel, C Kanagaratham, D Radzioch, I Kema, N Gilmore, P Ancuta, J Singer and M-A Jenabian

    Article first published online : 2 JUN 2014, DOI: 10.1111/hiv.12171

  20. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

    HIV Medicine

    M Mansfeld, A Skrahina, L Shepherd, A Schultze, AM Panteleev, RF Miller, JM Miro, I Zeltina, S Tetradov, H Furrer, O Kirk, A Grzeszczuk, N Bolokadze, A Matteelli, FA Post, JD Lundgren, A Mocroft, AMW Efsen, DN Podlekareva and for the TB:HIV study group in EuroCoord

    Article first published online : 11 MAY 2015, DOI: 10.1111/hiv.12256